Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Accenture: Q4 Earnings Insights

Accenture (NYSE:ACN) reported its Q4 earnings results on Thursday, September 22, 2022 at 06:45 AM. Here's what investors need to know about the announcement. Earnings Accenture beat estimated earnings by 1.17%, reporting an EPS of $2.6 versus an estimate of $2.57.
byBenzinga Insights
September 22, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Accenture (NYSE:ACN) reported its Q4 earnings results on Thursday, September 22, 2022 at 06:45 AM.

Here’s what investors need to know about the announcement.

Earnings

Accenture beat estimated earnings by 1.17%, reporting an EPS of $2.6 versus an estimate of $2.57.

Revenue was up $2.00 billion from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 4.74% increase in the share price the next day.

Here’s a look at Accenture’s past performance:

 

Quarter Q3 2022 Q2 2022 Q1 2022 Q4 2021
EPS Estimate 2.74 2.20 2.36 2.19
EPS Actual 2.79 2.54 2.78 2.20
Revenue Estimate 15.35B 13.44B 12.61B 13.42B
Revenue Actual 16.16B 15.05B 14.96B 13.42B

To track all earnings releases for Accenture visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cannabis Giant Tilray Reports 30% YoY Increase In Q3 Net Revenue, Updates FY 2024 Guidance

By Jelena Martinovic
April 9, 8:48 AM
Tilray Brands reported on Tuesday financial results for its third quarter ended Feb. 29, 2024, revealing $188.3 million in net revenue, representing a 30% year-over-year increase. The Canadian medical cannabis company said beverage-alcohol net revenue increased 165% over the same period to $54.7 million. Global cannabis net revenue was up 33% year-over-year reaching $63.4 million, with international cannabis growth of 44% over the prior year quarter. "We made several notable achievements during the third quarter, including growing revenue across our core business segments, increasing our adjusted gross profit, reducing our convertible debt balance, progressing the integration of our recently acquired craft beverage brands, realizing operating synergies in integrating our HEXO acquisition, completing our Canadian and international cannabis cost reduction plans, and strengthening our balance sheet," Irwin D. Simon, the company's chairman and CEO, said.

TLRY

Read More

Recap: Hologic Q3 Earnings

By Benzinga Insights
July 27, 5:44 PM
Hologic (NASDAQ:HOLX) reported its Q3 earnings results on Wednesday, July 27, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Hologic beat estimated earnings by 33.8%, reporting an EPS of $0.95 versus an estimate of $0.71.

HOLX